Abstract
Ehrlichia chaffeensis is an obligatory intracellular bacterium that causes human monocytic ehrlichiosis, an emerging, potentially fatal tick-borne infectious disease. The bacterium enters human cells via the binding of its unique outer-membrane invasin EtpE to the cognate receptor DNase X on the host-cell plasma membrane; this triggers actin polymerization and filopodia formation at the site of E. chaffeensis binding, and blocks activation of phagocyte NADPH oxidase that catalyzes the generation of microbicidal reactive oxygen species. Subsequently, the bacterium replicates by hijacking/dysregulating host-cell functions using Type IV secretion effectors. For example, the Ehrlichia translocated factor (Etf)-1 enters mitochondria and inhibits mitochondria-mediated apoptosis of host cells. Etf-1 also induces autophagy mediated by the small GTPase RAB5, the result being the liberation of catabolites for proliferation inside host cells. Moreover, Etf-2 competes with the RAB5 GTPase-activating protein, for binding to RAB5-GTP on the surface of E. chaffeensis inclusions, which blocks GTP hydrolysis and consequently prevents the fusion of inclusions with host-cell lysosomes. Etf-3 binds ferritin light chain to induce ferritinophagy to obtain intracellular iron. To enable E. chaffeensis to rapidly adapt to the host environment and proliferate, the bacterium must acquire host membrane cholesterol and glycerophospholipids for the purpose of producing large amounts of its own membrane. Future studies on the arsenal of unique Ehrlichia molecules and their interplay with host-cell components will undoubtedly advance our understanding of the molecular mechanisms of obligatory intracellular infection and may identify hitherto unrecognized signaling pathways of human hosts. Such data could be exploited for development of treatment and control measures for ehrlichiosis as well as other ailments that potentially could involve the same host-cell signaling pathways that are appropriated by E. chaffeensis.
Highlights
Ehrlichia chaffeensis is a tick-borne Gram-negative obligatory intracellular bacterium of the family Anaplasmataceae in the order Rickettsiales
Infection causes severe flu-like febrile disease called human monocytic ehrlichiosis (HME), which is often accompanied by hematologic abnormalities and signs similar to those of hepatitis (Dawson et al, 1991; Paddock and Childs, 2003)
This review primarily focuses on recent findings pertaining to invasin, Type IV secretion system (T4SS) effectors, and host-cell membrane lipids that are acquired by E. chaffeensis
Summary
E. chaffeensis has lost genes encoding major PAMPs such as lipopolysaccharide, peptidoglycan, flagella, and common pili (Lin and Rikihisa, 2003) It has a single small (1.18 Mbp) circular genome that lacks most genes for amino-acid biosynthesis and intermediary metabolism (Dunning Hotopp et al, 2006); the bacterium depends on host cells for these molecules. Ehrlichia chaffeensis inclusions rapidly fuse with host-cell early endosomes, thereby acquiring early-endosome markers including the small GTPase RAB5 and its effectors such as early endosome antigen 1, VPS34, and Rabankyrin-5. This facilitates subsequent fusion with other early endosomes that contain transferrin receptor (TfR). Readers are referred to several informative reviews for discussion of other aspects of E. chaffeensis (Paddock and Childs, 2003; Rikihisa, 2010; McBride and Walker, 2011; Rikihisa, 2011; Rikihisa, 2015; McClure et al, 2017; Byerly et al, 2021)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.